NM_012309.5:c.5151G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012309.5(SHANK2):​c.5151G>A​(p.Met1717Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,612,480 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 16 hom. )

Consequence

SHANK2
NM_012309.5 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.428

Publications

11 publications found
Variant links:
Genes affected
SHANK2 (HGNC:14295): (SH3 and multiple ankyrin repeat domains 2) This gene encodes a protein that is a member of the Shank family of synaptic proteins that may function as molecular scaffolds in the postsynaptic density of excitatory synapses. Shank proteins contain multiple domains for protein-protein interaction, including ankyrin repeats, and an SH3 domain. This particular family member contains a PDZ domain, a consensus sequence for cortactin SH3 domain-binding peptides and a sterile alpha motif. The alternative splicing demonstrated in Shank genes has been suggested as a mechanism for regulating the molecular structure of Shank and the spectrum of Shank-interacting proteins in the postsynaptic densities of the adult and developing brain. Alterations in the encoded protein may be associated with susceptibility to autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
SHANK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, 17
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024030209).
BP6
Variant 11-70473268-C-T is Benign according to our data. Variant chr11-70473268-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00267 (407/152202) while in subpopulation NFE AF = 0.00321 (218/68014). AF 95% confidence interval is 0.00286. There are 4 homozygotes in GnomAd4. There are 216 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 407 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012309.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK2
NM_012309.5
MANE Select
c.5151G>Ap.Met1717Ile
missense
Exon 26 of 26NP_036441.2
SHANK2
NM_001441024.1
c.5271G>Ap.Met1757Ile
missense
Exon 24 of 24NP_001427953.1
SHANK2
NM_001441025.1
c.5100G>Ap.Met1700Ile
missense
Exon 23 of 23NP_001427954.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK2
ENST00000601538.6
TSL:5 MANE Select
c.5151G>Ap.Met1717Ile
missense
Exon 26 of 26ENSP00000469689.2
SHANK2
ENST00000409161.5
TSL:1
c.3363G>Ap.Met1121Ile
missense
Exon 10 of 10ENSP00000386491.1
SHANK2
ENST00000916035.1
c.5100G>Ap.Met1700Ile
missense
Exon 23 of 23ENSP00000586094.1

Frequencies

GnomAD3 genomes
AF:
0.00268
AC:
407
AN:
152084
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0161
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00320
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00293
AC:
735
AN:
250802
AF XY:
0.00300
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0184
Gnomad NFE exome
AF:
0.00267
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00178
AC:
2601
AN:
1460278
Hom.:
16
Cov.:
32
AF XY:
0.00190
AC XY:
1377
AN XY:
726104
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33450
American (AMR)
AF:
0.000201
AC:
9
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86228
European-Finnish (FIN)
AF:
0.0174
AC:
930
AN:
53364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00140
AC:
1560
AN:
1110686
Other (OTH)
AF:
0.00159
AC:
96
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
165
330
494
659
824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00267
AC:
407
AN:
152202
Hom.:
4
Cov.:
33
AF XY:
0.00290
AC XY:
216
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41536
American (AMR)
AF:
0.000523
AC:
8
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.0161
AC:
170
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00321
AC:
218
AN:
68014
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00226
Hom.:
4
Bravo
AF:
0.00125
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00210
AC:
18
ExAC
AF:
0.00279
AC:
339
EpiCase
AF:
0.00213
EpiControl
AF:
0.00130

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
9.4
DANN
Benign
0.94
DEOGEN2
Benign
0.0079
T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.43
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.54
N
REVEL
Benign
0.062
Sift
Benign
0.42
T
Sift4G
Benign
0.48
T
Polyphen
0.0
B
Vest4
0.045
MVP
0.19
MPC
0.51
ClinPred
0.0075
T
GERP RS
0.46
gMVP
0.11
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140134890; hg19: chr11-70319373; COSMIC: COSV53620965; COSMIC: COSV53620965; API